Darifenacin HydrobromideExtended-Release (AvKARE, Inc.)
Welcome to the PulseAid listing for the Darifenacin Hydrobromide drug offered from AvKARE, Inc.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
| NON-PROPRIETARY NAME: | Darifenacin Hydrobromide |
| SUBSTANCE NAME: | DARIFENACIN HYDROBROMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-01-09 |
| END MARKETING DATE: | 0000-00-00 |
Darifenacin Hydrobromide Extended-Release HUMAN PRESCRIPTION DRUG Details:
| Item Description | Darifenacin Hydrobromide Extended-Release from AvKARE, Inc. |
| LABELER NAME: | AvKARE, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7.5(mg/1) |
| START MARKETING DATE: | 2017-01-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42291-206_85c0fe7d-4f79-4c82-9f5f-b821fe6a24bc |
| PRODUCT NDC: | 42291-206 |
| APPLICATION NUMBER: | ANDA091190 |
Other DARIFENACIN HYDROBROMIDE Pharmaceutical Manufacturers / Labelers:
